Enzyme Study Guide

📖 Core Concepts Enzyme: a protein (or catalytic RNA) that speeds up a reaction without being consumed; it lowers the activation energy but does not change the reaction equilibrium. Substrate → Product: substrate binds in the active site (catalytic + binding residues) and is converted to product. Specificity: dictated by the 3‑D shape and chemical environment of the active site; gives chemoselectivity, regio‑ and stereospecificity. EC Number (EC x.x.x.x): systematic classification; the first digit tells the overall reaction type (oxidoreductase, transferase, hydrolase, …). Isozyme: different proteins that catalyze the same reaction but have distinct sequences or regulation (e.g., hexokinase vs. glucokinase). Cofactor vs. Coenzyme vs. Prosthetic group: Cofactor – non‑protein component (metal ion or organic molecule). Coenzyme – loosely bound organic cofactor that participates in the reaction (e.g., NAD⁺, ATP). Prosthetic group – tightly bound cofactor (e.g., biotin). Holoenzyme / Apoenzyme: holoenzyme = protein + required cofactor(s); apoenzyme = protein alone. Kinetic parameters: Vmax – maximal rate when all sites are saturated. Km – substrate concentration at ½ Vmax (inverse affinity). kcat – turnovers per active site per second. kcat/Km – catalytic efficiency (higher = “better” enzyme). --- 📌 Must Remember Enzymes do not change equilibrium; they only speed up reaching it. EC 1–7 categories (oxidoreductases → translocases). Lock‑and‑key = rigid fit; induced fit = active‑site reshaping on binding. Four catalytic strategies: transition‑state stabilization, covalent catalysis, ground‑state destabilization, entropy reduction. Inhibition types: Competitive ↑Km, Vmax unchanged. Non‑competitive (pure) ↓Vmax, Km unchanged. Uncompetitive ↓Km & Vmax (both parallel). Mixed → both Km and Vmax change (asymmetric). Irreversible = covalent inactivation (e.g., penicillin). Catalytically perfect enzymes operate at diffusion limit (10⁸–10⁹ M⁻¹ s⁻¹). Isozyme functional difference: glucokinase has low glucose affinity → acts as glucose sensor. --- 🔄 Key Processes Michaelis–Menten mechanism \[ E + S \;\underset{k{-1}}{\overset{k1}{\rightleftharpoons}}\; ES \;\xrightarrow{k2}\; E + P \] Derive \(V = \frac{V{\max}[S]}{Km + [S]}\). Competitive inhibition \[ E + I \rightleftharpoons EI \quad (\text{blocks active site}) \] Apparent \(Km^{\text{app}} = Km\left(1 + \frac{[I]}{Ki}\right)\). Allosteric regulation (MWC or KNF models) – effector binding → conformational shift → activity ↑ or ↓. Enzyme induction – signal → increased transcription/translation → higher enzyme concentration (e.g., β‑lactamase). Proteolytic activation – zymogen → active enzyme (e.g., chymotrypsinogen → chymotrypsin). --- 🔍 Key Comparisons Lock‑and‑key vs. Induced fit Rigid complementarity vs. flexible reshaping upon substrate binding. Competitive vs. Non‑competitive inhibition Competes with substrate (↑Km, Vmax unchanged) vs. binds elsewhere (Vmax ↓, Km unchanged). Isozyme vs. Orthologous enzyme Same reaction, different gene & regulation (isozyme) vs. same gene family in different species (ortholog). Cofactor vs. Coenzyme Cofactor can be metal or organic; coenzyme is a loosely bound organic molecule that is transformed during the reaction. Holoenzyme vs. Apoenzyme Complete, active complex vs. protein alone (inactive until cofactor added). --- ⚠️ Common Misunderstandings “Enzymes change equilibrium.” False – they only accelerate the approach to equilibrium. “Km = Kd.” Not exactly; Km reflects both binding affinity and catalytic turnover, especially when \(k{cat}\) ≠ 0. “All inhibitors are reversible.” Irreversible covalent inhibitors exist (penicillin, aspirin). “Isozymes are identical.” They differ in kinetics, regulation, or tissue distribution. “Higher temperature always increases rate.” Beyond the optimum, enzymes denature and lose activity. --- 🧠 Mental Models / Intuition “Enzyme as a hand” – the palm (binding site) holds the substrate, the thumb (catalytic residues) performs the chemistry. “Transition‑state umbrella” – the enzyme creates an environment that fits the transition state better than the substrate, thus lowering ΔG‡. “Traffic jam analogy for inhibition” – competitive inhibitor = a car parked in the lane (active site); non‑competitive = a roadblock on a side street (allosteric site). “Diffusion limit ceiling” – imagine a relay race where the runner (enzyme) can only run as fast as the baton can be handed over; perfect enzymes run at that maximal hand‑off speed. --- 🚩 Exceptions & Edge Cases Allosteric activation vs. inhibition – same binding site can act oppositely depending on the effector’s nature. Isozyme expression – some tissues express multiple isozymes; loss of one may be compensated (e.g., hexokinase I vs. glucokinase). Irreversible inhibitors can sometimes be rescued by new enzyme synthesis (cellular turnover). Non‑homologous isofunctional enzymes share EC numbers but have unrelated sequences. --- 📍 When to Use Which Identify reaction type → pick EC class (oxidoreductase = EC 1, etc.). If substrate is a phosphate donor/acceptor → likely a kinase (EC 2.7). For hydrolysis of a peptide bond → hydrolase (EC 3). When a rapid, diffusion‑limited rate is observed → suspect a “catalytically perfect” enzyme (e.g., carbonic anhydrase). If a drug is metabolized variably among patients → consider cytochrome P450 induction or inhibition. --- 👀 Patterns to Recognize “Low Km & high kcat” → high affinity and fast turnover → often a key regulatory step. Competitive inhibitor structural mimicry – look for inhibitors that resemble the substrate’s transition state. Isozyme tissue‑specificity – enzymes with similar reactions but different kinetic parameters often map to distinct organs (e.g., glucokinase in liver/pancreas). Feedback inhibition – product of a pathway binding upstream enzyme → classic negative feedback pattern. --- 🗂️ Exam Traps Confusing Km with substrate concentration – remember Km is a constant, not a variable. Choosing “non‑competitive” when Vmax is unchanged – that describes pure competitive inhibition; non‑competitive always lowers Vmax. Assuming all allosteric regulators are inhibitors – some are activators (e.g., phosphofructokinase activation by ADP). Mixing up coenzyme vs. prosthetic group – coenzymes dissociate after reaction; prosthetic groups stay bound. Over‑applying the lock‑and‑key model – modern consensus favors induced fit; lock‑and‑key is an oversimplification. ---